BACKGRO UND : Gastric protection is commonly considered in patients who use medications able to damage gastric mucosa, mainly NSAID s, antiplatelets, and anticoagulants. Therefore, cardiologists may frequently prescribe drugs to protect the stomach from damaging medications. The present survey investigated the attitude toward using gastric protection by a panel of Italian cardiologists. METHOD S: A self-administered questionnaire included three sections concerning practical problems on this issue in clinical practice facing patients with cardiological disorders. The questionnaire was administered in three successive months. RE SULTS: Ninety Italian cardiologists completed the questionnaire. They all consider gastric protection, mainly when prescribing potentially noxious medications. Usually, cardiologists prescribe proton pump inhibitors (PPIs) in 60% of their patients. Alginates and mucosal protectors are less considered. As a rule, cardiologists request investigations if the initial treatment fails. Moreover, the safety issue is carefully assessed. Furthermore, this survey experience significantly affected the approach to managing patients who require gastric protection. The participants carefully considered the prescriptive appropriateness of gastric protectors, mainly concerning the PPIs use. Consequently, PPIs were discontinued when inappropriate. A new medical device with triple action (antacid, mucosal protectors, and anti-reflux) contributed to this new attitude. CON CLUSION S: The present survey underscored that the appropriateness in prescribing gastric protectors is clinically relevant. In addition, a longitudinal survey experience contributed to change the practical approach by highlighting the prescriptive appropriateness of PPIs, and using a new medical device with multiple gastroprotective activities. (Cite this article as: Aragona SE, Margonato A, Felis S, Crisci M, Ciprandi G; the Pirocardio Study Group. Gastric protection

Salvatore ARAGONA, A.M. (2024). Gastric protection in cardiological practice: an Italian survey on the prescriptive attitude. MINERVA CARDIOLOGY AND ANGIOLOGY, 72(1) [10.23736/S2724-5683.23.06438-4].

Gastric protection in cardiological practice: an Italian survey on the prescriptive attitude

SUCATO VINCENZO
Membro del Collaboration Group
2024-02-01

Abstract

BACKGRO UND : Gastric protection is commonly considered in patients who use medications able to damage gastric mucosa, mainly NSAID s, antiplatelets, and anticoagulants. Therefore, cardiologists may frequently prescribe drugs to protect the stomach from damaging medications. The present survey investigated the attitude toward using gastric protection by a panel of Italian cardiologists. METHOD S: A self-administered questionnaire included three sections concerning practical problems on this issue in clinical practice facing patients with cardiological disorders. The questionnaire was administered in three successive months. RE SULTS: Ninety Italian cardiologists completed the questionnaire. They all consider gastric protection, mainly when prescribing potentially noxious medications. Usually, cardiologists prescribe proton pump inhibitors (PPIs) in 60% of their patients. Alginates and mucosal protectors are less considered. As a rule, cardiologists request investigations if the initial treatment fails. Moreover, the safety issue is carefully assessed. Furthermore, this survey experience significantly affected the approach to managing patients who require gastric protection. The participants carefully considered the prescriptive appropriateness of gastric protectors, mainly concerning the PPIs use. Consequently, PPIs were discontinued when inappropriate. A new medical device with triple action (antacid, mucosal protectors, and anti-reflux) contributed to this new attitude. CON CLUSION S: The present survey underscored that the appropriateness in prescribing gastric protectors is clinically relevant. In addition, a longitudinal survey experience contributed to change the practical approach by highlighting the prescriptive appropriateness of PPIs, and using a new medical device with multiple gastroprotective activities. (Cite this article as: Aragona SE, Margonato A, Felis S, Crisci M, Ciprandi G; the Pirocardio Study Group. Gastric protection
feb-2024
Salvatore ARAGONA, A.M. (2024). Gastric protection in cardiological practice: an Italian survey on the prescriptive attitude. MINERVA CARDIOLOGY AND ANGIOLOGY, 72(1) [10.23736/S2724-5683.23.06438-4].
File in questo prodotto:
File Dimensione Formato  
Gastric pyrosis and hyperacidity.pdf

Solo gestori archvio

Tipologia: Versione Editoriale
Dimensione 605.44 kB
Formato Adobe PDF
605.44 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/636396
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact